Table 3 Summary of the RNA-seq outcomes of 15 separately pooled samples

H1–10

28.874

26.955 (93.35%)

23.163 (80.22%)

3.792 (13.13%)

44.92

89.56

H1–15

46.506

43.543 (93.63%)

35.628 (76.61%)

7.914 (17.02%)

45.01

89.88

H1–20

58.818

54.118 (92.01%)

46.657 (79.33%)

7.460 (12.68%)

45.32

89.59

H1–25

74.935

69.157 (92.29%)

60.808 (81.15%)

8.349 (11.14%)

44.83

90.04

H1–28

45.842

42.186 (92.02%)

37.261 (81.28%)

4.924 (10.74%)

44.87

91.56

H2–10

41.384

39.026 (94.30%)

32.371 (78.22%)

6.656 (16.08%)

45.16

90.86

H2–15

51.063

47.661 (93.34%)

38.451 (75.30%)

9.210 (18.04%)

44.98

89.02

H2–20

47.327

44.331 (93.67%)

37.008 (78.20%)

7.323 (15.47%)

45.54

90.28

H2–25

46.285

43.048 (93.01%)

36.495 (78.85%)

6.553 (14.16%)

45.03

90.69

H2–28

46.911

43.217 (92.12%)

36.480 (77.76%)

6.737 (14.36%)

44.79

90.31

Z36–10

32.345

30.236 (93.48%)

25.116 (77.65%)

5.121 (15.83%)

44.79

89.64

Z36–15

41.266

38.850 (94.14%)

31.683 (76.78%)

7.167 (17.37%)

44.97

90.95

Z36–20

47.377

43.552 (91.93%)

36.464 (76.97%)

7.087 (14.96%)

45.26

90.27

Z36–25

47.471

43.736 (92.13%)

38.161 (80.39%)

5.575 (11.74%)

45.28

90.66

Z36–28

49.029

45.590 (92.99%)

33.337 (67.99%)

12.253 (24.99%)

46.20

90.55